Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Dec 06, 2017

Botox Gets A Rival: Charts

Botox Gets A Rival: Charts

(Bloomberg Gadfly) -- Good morning! This is Fly Charts, the daily charts-only newsletter from Gadfly; sign up here. From IPO doubt to Lands' End misery, here are four charts that tell you what you need to know in business today.

And don't miss Tara Lachapelle on Charlie Ergen's mysterious moves: "Deja vu has become a running theme at Dish, between the endless decline of satellite-video subscribers and the repetitious promise of a bright, futuristic vision for Dish's role in the wireless market -- a market in which it's not even a true player yet. This also isn't the first time Ergen has stepped back from his day-to-day CEO responsibilities to pursue grander plans. He did so six years ago and the result was a deal offensive, albeit an unsuccessful one."

This column does not necessarily reflect the opinion of Bloomberg LP and its owners.

Max Nisen is a Bloomberg Gadfly columnist covering biotech, pharma and health care. He previously wrote about management and corporate strategy for Quartz and Business Insider.

To contact the author of this story: Max Nisen in New York at mnisen@bloomberg.net.

To contact the editor responsible for this story: Mark Gongloff at mgongloff1@bloomberg.net.

©2017 Bloomberg L.P.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source